In contrast, a previous study in infants, with a BPD prevalence of up to 80.4% over more than 6 years, indicated that low serum CXCL4 levels in premature infants one week after birth were linked to a higher risk and severity of BPD (Arjaans et al. 2020). Here, PF4 is linked to bronchopulmonary dysplasia.